JNJ Johnson & Johnson

127.73-3.54 (-2.70%)
Close: August 23, 2019

127.57-0.16 (-0.12%)
Pre-market

Quote

Previous Close
$127.73
Day Range
$127.13-$131.26
52 Week Range
$121.00-$148.99
Volume
15,652,519
Avg Volume
7,601,290
Dividend TTM
$3.65 (2.86%)
Ex-Dividend Date
2019-08-26

Valuation

Market Cap
$337.10B
Enterprise Value (EV)
$357.24B
PE Ratio
20.90
EV/EBITDA
12.68
Price/Sales
4.25
Price/Book
5.64
PEG Ratio
0.91

Financials

Revenue
$81.53B
Gross Profit
$54.35B
EBITDA
$28.18B
EPS, ttm
$6.11
Profit Margin
18.76%
Revenue/Employee
$603.51K
Next Earnings Date
10/15/2019 (51 days)
Debt to Equity
51%
Debt
$39.82B
Cash
$19.69B
Net Debt
$20.14B

Performance

Beta
0.59
200 Day Moving Avg
$136.35
50 Day Moving Avg
$134.93
52 Week Change
-6.05%
YTD Change
-2.71%
1 Month Change
-1.58%
3 Month Change
-8.01%
6 Month Change
-6.22%
1 Year Change
-6.05%
2 Year Change
15.29%
5 Year Change
40.81%

Share Count

Shares Outstanding
2.6B
Float
2.6B
Restricted Shares
3.1M
Restricted Shares, %
0.12%

Johnson & Johnson Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Alex Gorsky

Website: http://www.jnj.com

Description: Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Employees: 135,100